🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Endometrial Receptivity Prediction During in Vitro Fertilization Using Artificial Intelligence

Recruitingn/aAges 18 Years - 40 YearsFemaleGottsegen National Cardiovascular Institute
NCT06717802 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The investigators plan to use artificial intelligence to analyse vaginal ultrasound images of the uterine lining (endometrium) taken during routine IVF treatment, which may predict implantation success during IVF treatment. Participation in the study is voluntary, involves no additional testing or intervention beyond routine procedures, and consent can be withdrawn verbally or in writing at any time without cause or adverse consequences. Over a three-year period, the trial is expected to enrol approximately 1,500 patients between the ages of 18 and 40 who are indicated for IVF treatment and who volunteer for treatment. Patients enrolled in the study will not be required to attend more clinic visits during treatment than they would otherwise have to. During the trial, certain patient-specific data (age, indication for treatment, body mass index), stimulation-specific data (duration of

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Female patient 18-40 years, for whom IVF is indicated * Maximum 3 unsuccessful previous embryo transfers * Only cycles in which single blastocyst is transferred Exclusion Criteria: * Congenital uterine anomalies, fibroids, adenomyosis, Asherman-syndrome or any other conditions resulting in malformation of the uterus * Presence of hydrosalpinx * Endometriosis * Planned freeze-all cycle * Positive hepatitis B, hepatitis C or HIV screening test
💊

What it tests

  • Not listed
📍

Where

1 site
Dunamenti REK Reprodukcios Kozpont
Budapest, Hungary
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy